These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 12915559)

  • 21. Genetic engineering of onco/lentivirus hybrids results in formation of infectious but not of replication-competent viruses.
    Steidl S; Schüle S; Mühlebach MD; Stitz J; Boller K; Cichutek K; Schweizer M
    J Gen Virol; 2004 Mar; 85(Pt 3):665-678. PubMed ID: 14993652
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stable transduction of quiescent CD34(+)CD38(-) human hematopoietic cells by HIV-1-based lentiviral vectors.
    Case SS; Price MA; Jordan CT; Yu XJ; Wang L; Bauer G; Haas DL; Xu D; Stripecke R; Naldini L; Kohn DB; Crooks GM
    Proc Natl Acad Sci U S A; 1999 Mar; 96(6):2988-93. PubMed ID: 10077624
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Performance- and safety-enhanced lentiviral vectors containing the human interferon-beta scaffold attachment region and the chicken beta-globin insulator.
    Ramezani A; Hawley TS; Hawley RG
    Blood; 2003 Jun; 101(12):4717-24. PubMed ID: 12586614
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Helper virus induced T cell lymphoma in nonhuman primates after retroviral mediated gene transfer.
    Donahue RE; Kessler SW; Bodine D; McDonagh K; Dunbar C; Goodman S; Agricola B; Byrne E; Raffeld M; Moen R
    J Exp Med; 1992 Oct; 176(4):1125-35. PubMed ID: 1383375
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hybrid HIV/MSCV LTR enhances transgene expression of lentiviral vectors in human CD34(+) hematopoietic cells.
    Choi JK; Hoang N; Vilardi AM; Conrad P; Emerson SG; Gewirtz AM
    Stem Cells; 2001; 19(3):236-46. PubMed ID: 11359949
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transduction of human CD34+ CD38- bone marrow and cord blood-derived SCID-repopulating cells with third-generation lentiviral vectors.
    Guenechea G; Gan OI; Inamitsu T; Dorrell C; Pereira DS; Kelly M; Naldini L; Dick JE
    Mol Ther; 2000 Jun; 1(6):566-73. PubMed ID: 10933981
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The long terminal repeat negative control region is a critical element for insertional oncogenesis after gene transfer into hematopoietic progenitors with Moloney murine leukemia viral vectors.
    Ikawa Y; Uchiyama T; Jagadeesh GJ; Candotti F
    Gene Ther; 2016 Nov; 23(11):815-818. PubMed ID: 27487944
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Two factors that bind to highly conserved sequences in mammalian type C retroviral enhancers.
    Manley NR; O'Connell M; Sun W; Speck NA; Hopkins N
    J Virol; 1993 Apr; 67(4):1967-75. PubMed ID: 8445718
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of retrovirus vectors useful for expressing genes in cultured murine embryonal cells and hematopoietic cells in vivo.
    Guild BC; Finer MH; Housman DE; Mulligan RC
    J Virol; 1988 Oct; 62(10):3795-801. PubMed ID: 3418785
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inactivation of the Moloney murine leukemia virus long terminal repeat in murine fibroblast cell lines is associated with methylation and dependent on its chromosomal position.
    Hoeben RC; Migchielsen AA; van der Jagt RC; van Ormondt H; van der Eb AJ
    J Virol; 1991 Feb; 65(2):904-12. PubMed ID: 1702844
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Self-inactivating retroviral vector-mediated gene transfer induces oncogene activation and immortalization of primary murine bone marrow cells.
    Bosticardo M; Ghosh A; Du Y; Jenkins NA; Copeland NG; Candotti F
    Mol Ther; 2009 Nov; 17(11):1910-8. PubMed ID: 19638958
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhanced transgene expression in primitive hematopoietic progenitor cells and embryonic stem cells efficiently transduced by optimized retroviral hybrid vectors.
    Ketteler R; Glaser S; Sandra O; Martens UM; Klingmüller U
    Gene Ther; 2002 Apr; 9(8):477-87. PubMed ID: 11948372
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Distinct genomic integration of MLV and SIV vectors in primate hematopoietic stem and progenitor cells.
    Hematti P; Hong BK; Ferguson C; Adler R; Hanawa H; Sellers S; Holt IE; Eckfeldt CE; Sharma Y; Schmidt M; von Kalle C; Persons DA; Billings EM; Verfaillie CM; Nienhuis AW; Wolfsberg TG; Dunbar CE; Calmels B
    PLoS Biol; 2004 Dec; 2(12):e423. PubMed ID: 15550989
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activity of Friend mink cell focus-forming retrovirus during myelo-erythroid hematopoiesis.
    Baum C; Eckert HG; Stocking C; Ostertag W
    Exp Hematol; 1996 Feb; 24(2):364-70. PubMed ID: 8641367
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Replication of a Moloney murine leukemia virus mutant lacking the ELP binding site.
    Coulombe J; Dubé M; Gray DA
    Virology; 1994 Aug; 203(1):162-5. PubMed ID: 8030273
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of novel efficient SIN vectors with improved safety features for Wiskott-Aldrich syndrome stem cell based gene therapy.
    Avedillo Díez I; Zychlinski D; Coci EG; Galla M; Modlich U; Dewey RA; Schwarzer A; Maetzig T; Mpofu N; Jaeckel E; Boztug K; Baum C; Klein C; Schambach A
    Mol Pharm; 2011 Oct; 8(5):1525-37. PubMed ID: 21851067
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transplantation of transduced nonhuman primate CD34+ cells using a gibbon ape leukemia virus vector: restricted expression of the gibbon ape leukemia virus receptor to a subset of CD34+ cells.
    Bunnell BA; Kluge KA; Lee-Lin SQ; Byrne ER; Orlic D; Metzger ME; Agricola BA; Wersto RP; Bodine DM; Morgan RA; Donahue RE
    Gene Ther; 1999 Jan; 6(1):48-56. PubMed ID: 10341875
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Simplified retroviral vector gcsap with murine stem cell virus long terminal repeat allows high and continued expression of enhanced green fluorescent protein by human hematopoietic progenitors engrafted in nonobese diabetic/severe combined immunodeficient mice.
    Kaneko S; Onodera M; Fujiki Y; Nagasawa T; Nakauchi H
    Hum Gene Ther; 2001 Jan; 12(1):35-44. PubMed ID: 11177540
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Retroviral vector gene expression in F9 embryonal carcinoma cells.
    Linney E; Neill SD; Prestridge DS
    J Virol; 1987 Oct; 61(10):3248-53. PubMed ID: 3041045
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Core-binding factor influences the disease specificity of Moloney murine leukemia virus.
    Lewis AF; Stacy T; Green WR; Taddesse-Heath L; Hartley JW; Speck NA
    J Virol; 1999 Jul; 73(7):5535-47. PubMed ID: 10364302
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.